Investing Profile

Nadiya Ishnazarova

InvestorVC
Principal at M Ventures
Netherlands
Photo of Nadiya Ishnazarova, Principal at MDC Ventures (formerly KBS Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Oxford Network
267 CONNECTIONS
University of Oxford Network
267 CONNECTIONS
Johnson & Johnson Network
57 CONNECTIONS
Oliver Wyman Network
48 CONNECTIONS
Oliver Wyman Network
48 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
CompanyStageDateRound SizeTotal Raised
Iktos
Series AMar 2023$16M
$16M
Research Assistant DESYPresent
Tutor University of OxfordPresent
Postdoctoral Researcher University of OxfordPresent
Consultant Oliver WymanPresent
Senior Consultant Oliver WymanPresent
Associate | Project manager - Health & Life sciences Oliver WymanPresent
Board Observer Metabomed Ltd.Present
Associate M VenturesPresent
Board Observer ActitheraPresent
Board Observer AstraveusPresent
Board Observer Nucleome TherapeuticsPresent
Board Member IktosPresent
Board Observer Ribometrix Inc.Present
Board Observer Future FertilityPresent
Board Observer CellFEPresent
Board Member ImmuneBridgePresent
Board Member ReproNovoPresent
Board Member Sentaur Bio Ltd.Present
Principal M VenturesPresent
Board Observer ReproNovoPresent
Board Member Future FertilityPresent
Board Member FoRx TherapeuticsPresent
Senior Director Johnson & JohnsonPresent
Board Member Nucleome TherapeuticsPresent
Board Member Asgard TherapeuticsPresent
Lomonosov Moscow State University (MSU) Specialist in Chemistry (M.Sc.) Chemistry, Chemical Enzymology
Lomonosov Moscow State University (MSU) Specialist in Medicinal Chemistry (M.Sc.) Chemistry, Medicinal Chemistry, Chemical Enzymology
University of Oxford Doctor of Philosophy (Ph.D.) Biochemistry
University of Oxford Doctor of Philosophy (Ph.D.) Biochemistry and Molecular Genetics